<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yoshitaka Gunji | Higashikuni Lab</title><link>https://www.higashikuni-lab.org/authors/yoshitaka-gunji/</link><atom:link href="https://www.higashikuni-lab.org/authors/yoshitaka-gunji/index.xml" rel="self" type="application/rss+xml"/><description>Yoshitaka Gunji</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 01 Apr 2026 20:34:17 +0000</lastBuildDate><image><url>https://www.higashikuni-lab.org/media/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url><title>Yoshitaka Gunji</title><link>https://www.higashikuni-lab.org/authors/yoshitaka-gunji/</link></image><item><title>Positioning esaxerenone, a non-steroidal mineralocorticoid receptor antagonist, in the treatment of hypertension with and without hemodynamic cardiac stress</title><link>https://www.higashikuni-lab.org/publication/esaxerenone-hf2026/</link><pubDate>Wed, 01 Apr 2026 20:34:17 +0000</pubDate><guid>https://www.higashikuni-lab.org/publication/esaxerenone-hf2026/</guid><description/></item></channel></rss>